Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe. - Wikidata - wikimedia - TriplyDB

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

http://www.wikidata.org/entity/Q33984025

about

Four Statin Benefit Groups Defined by The 2013 ACC/AHA New Cholesterol Guideline are Characterized by Increased Plasma Level of Electronegative Low-Density Lipoprotein.Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia.

P2860

Q37448634-A5CB06EE-D2A6-44FA-996F-1B9CE9175536 Q47785743-5F84D7FA-977C-4CC6-90B4-83ED6767DD57

P2860

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

http://www.wikidata.org/entity/Q33984025

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@ast

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@en

type

label

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@ast

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@en

prefLabel

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@ast

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@en

P1433

Q33984025-3FA1BB94-FB75-4F9A-840E-493D0A3B3791

P1476

Q33984025-54BC1108-91F3-4273-9BB1-82C5D31E2321

P2093

Q33984025-05063551-E9AB-4F7A-91EA-1F4CD2B80D90

Q33984025-47FD1EA9-3A61-466C-9757-FD07B28F7D63

Q33984025-48E8AD82-F7EC-4294-BFA7-105F50B71592

Q33984025-4A2A4D76-CB98-44B2-89B9-FA59C122C40E

Q33984025-6430F466-DCB6-47A3-BB3E-FF69A1E4AC4F

Q33984025-75B271A2-AF6C-42F1-BD0C-72168F2EE33A

Q33984025-88B9AC83-B295-4063-9AD2-A04A5A7A6160

Q33984025-A37B5739-B99F-4964-99A3-CBA689D152CC

Q33984025-BAD57DCE-47E4-4B35-9BB4-F63E83391BCD

Q33984025-DF4B4791-1C7E-420C-A464-C79DB948D3DA

P2860

Q33984025-1CA40B6F-8EAB-4930-A3B8-72D976DE9AED

Q33984025-23B3BD5D-6341-4796-9D50-23B2D6D7C2B9

Q33984025-33B844DB-D3DE-43AE-BB73-3E6C85565D18

Q33984025-3712F043-95F3-430E-8524-0AE95FF389F5

Q33984025-37F5C29E-339E-4211-92F4-650B66BDD549

Q33984025-3A61A777-582F-4420-9608-0290A361CF9D

Q33984025-3AD1FF5F-E945-4238-ABD0-A4B5DBDBBA28

Q33984025-558636D6-8204-4336-9FC7-1BBBCF4941B2

Q33984025-59C6E41B-57C3-4153-A73D-B1893A402280

Q33984025-839C5A8E-53F3-44F8-876B-C75024E73D06

P304

Q33984025-2516C643-8B44-4361-B972-7F16F0DCB76F

P31

Q33984025-4B594444-3D11-43C2-AAE4-14A480EDF8AC

P356

Q33984025-3183E1CC-5E98-4C29-9EB7-111C887BCB9A

P433

Q33984025-1043CED5-8C79-4A55-9BC7-7DBAE6C347C5

P478

Q33984025-0EDD959B-206E-4DDA-A158-EF6D28EC749B

P50

Q33984025-7ADFB58B-5E07-4B68-8120-83B56242D8BC

P577

Q33984025-FE6FF01F-ABE9-46C8-92FA-61B30000DAAE

P5875

Q33984025-E6A04EA1-95D8-46AA-B92B-5A14EA7C5F6B

P698

Q33984025-5D2EE13A-F67B-4F28-B936-88316E16A24A

P921

Q33984025-264E925F-8981-4009-A940-C42407541911

P932

Q33984025-C1CDFD53-CDB4-4644-A9FD-295B86275618

P356

KCJ.2014.44.4.227

P1433

Korean circulation journal

P1476

Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.

@en

P2093

Chee Jeong Kim

http://www.w3.org/2001/XMLSchema#string

Cheol Won Hyeon

http://www.w3.org/2001/XMLSchema#string

Jee Eun Kwon

http://www.w3.org/2001/XMLSchema#string

Kwang Je Lee

http://www.w3.org/2001/XMLSchema#string

Sang-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Seonghyup Hyun

http://www.w3.org/2001/XMLSchema#string

Seung Yong Shin

http://www.w3.org/2001/XMLSchema#string

Tae Ho Kim

http://www.w3.org/2001/XMLSchema#string

Wang-Soo Lee

http://www.w3.org/2001/XMLSchema#string

Young Hwan Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

Beneficial cardiovascular pleiotropic effects of statins.

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia.

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Inhibition of intestinal cholesterol absorption by ezetimibe in humans.

P304

227-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4070/KCJ.2014.44.4.227

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264463026

http://www.w3.org/2001/XMLSchema#string

P698

25089134

http://www.w3.org/2001/XMLSchema#string

P921

P932

4117843

http://www.w3.org/2001/XMLSchema#string